Danaher Corporation acquires Beckman Coulter, Inc.

Danaher Corporation acquired Beckman Coulter, Inc. for approximately $6.8 billion ($83.50 per share cash tender offer; total enterprise value including debt assumed and net of cash acquired), a transaction completed in June 2011, structured as all cash (cash tender offer and second-step merger).

Beckman Coulter, Inc. operates in Diagnostics / Life Sciences, is based in Brea, California, USA, had revenue of about approximately $3.7 billion in annual revenues. Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Its diagnostic systems are found in hospitals and other clinical settings worldwide and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients; its life-science research instruments are used to study complex biological problems.

Beckman Coulter is an iconic company with a great brand, broad reach and technology leadership, well positioned in the markets it serves; it provides an excellent complement to Danaher's existing Life Sciences & Diagnostics businesses.

The $83.50 offer represented a premium of approximately 45% to Beckman Coulter's closing price on December 9, 2010, the date market speculation about a sale began. Danaher Life Sciences & Diagnostics segment (joining Leica, AB Sciex, Radiometer and Molecular Devices)

Advisory firms were not disclosed for this transaction.